C4 Therapeutics Inc
CCCC · NASDAQ3.69
3.69
USD0.195.58%Balance Sheet
Total Assets
118.26M
400.14M
Liabilities And Stockholders Equity
118.26M
400.14M
Income Statement
Total Revenue
21.38M
33.2M
Cost Of Revenue
47.66M
77.47M
Gross Profit
-26.28M
-44.27M
Total Operating Expenses
56.83M
93.64M
Operating Income
-35.45M
-60.45M
Income Before Tax
-33.3M
-66.96M
Net Income After Taxes
-34.1M
-66.33M
Net Income Before Extraordinary Items
-34.1M
-66.33M
Net Income
-34.1M
-66.33M
Net Income Applicable To Common Shares
-42.57M
-66.33M
Diluted Net Income
-42.57M
-66.33M
Diluted Weighted Average Shares
17.23
40.77
Diluted EPS Excluding Extraordinary Items
-1.98
-1.63
Diluted Normalized EPS
-2.47
-1.63
EBIT
-35.45M
-65.73M
Cash Flow
Total Cash From Operating Activities
55.61M
-67.25M
Total Cash Flows From Investing Activities
-1.62M
-190.5M
Total Cash From Financing Activities
244K
348.93M
Exchange Rate Changes
-
-
Change In Cash
54.24M
91.18M
Free Cash Flow
54.27M
-67.9M
What are you waiting for?Start making profit today
©
2025
All rights reserved